H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.4% of adults in Norfolk have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Census population 238,005. Virginia Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Norfolk clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Norfolk storefront.
Build Your Biologic Treatment Center in Norfolk, VA for clinics & physicians. Start or expand your biologi… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of biologic treatment center in Norfolk: (1) CDC PLACES (2023, crude) estimates 12.4% of adults in Norfolk have diagnosed diabetes — 0.4 points above the U.S. 12% figure. (2) Virginia Part B wound biologics are reviewed by Palmetto GBA under JM, shared with NC, SC, WV. We help with the second file. We do not pretend to be a Norfolk storefront.
National Build Your Biologic Treatment Center notes (how the product actually works)10.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 238,005 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12.4% of adults in Norfolk have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 12.4% of adults in Norfolk have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Adult arthritis here is 22.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Norfolk.
CDC PLACES (2023, crude prevalence) estimates 12.4% of adults — 0.4 points above the U.S. 12% figure. Obesity is 39.9%; arthritis is 22.6%. That is place-level BRFSS modeling, not a clinic census and not a Norfolk trial.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Palmetto GBA LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JM reviewers and surveyors expect — not a brochure.
Bring specialty, monthly joint / regenerative volume, and whether you bill JM FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.4% diabetes and 22.6% arthritis for Norfolk — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Norfolk, VA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Norfolk is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Norfolk — 0.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Virginia Part B wound biologics follow this contractor (siblings: NC, SC, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Norfolk. Useful for joint-program math; still needs a diagnosis and privileging.
No Norfolk storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.